Results 271 to 280 of about 473,635 (345)

Population-Based Estimates of Hepatitis E Virus-Associated Mortality in Bangladesh. [PDF]

open access: yesJ Infect Dis
Paul RC   +12 more
europepmc   +1 more source

Seroprevalencia de virus hepatitis E en donantes de sangre en un hospital universitario en Chile.

open access: green, 2019
Natalia Covarrubías   +7 more
openalex   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott   +10 more
wiley   +1 more source

High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany. [PDF]

open access: yesOne Health
Hinte F   +6 more
europepmc   +1 more source

External cephalic version outcomes with tocolysis and sedation: A 10‐year retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate the effectiveness and safety of external cephalic version (ECV) performed with tocolysis and sedation or spinal anesthesia, and to identify predictors of ECV success, complications, and delivery outcomes after successful ECV. Methods This 10‐year cohort study included 990 pregnant women with term non‐cephalic presentation
Javier Sánchez‐Romero   +7 more
wiley   +1 more source

Cholestasis in hepatitis E virus infection. [PDF]

open access: yesWorld J Hepatol
Kanda T   +6 more
europepmc   +1 more source

Retrospective Analysis of Blood Donor Deferral Reasons and Optimization Suggestions for Deferral Policies

open access: yesiLABMED, EarlyView.
This retrospective study analyzes the deferral reasons for 148,282 blood donors during 2019–2023 (overall deferral rate: 12.37%), identifying primary deferral reasons (e.g., elevated ALT for temporary deferral at 51.33%, HBsAg positivity for permanent deferral at 4.12%).
Limei Feng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy